Project Grant R33DA059831
- Federal Grant Award Summary Kaiser Foundation Hospitals, operating through the Kaiser Foundation Research Institute in Hawaii, received a $1.422 million Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate a mobile health (mHealth) intervention targeting substance use and HIV risk reduction for young adult women affected by sex trafficking. The project, awarded June 15, 2025, with a completion...
- Federal Project Grant Award Summary Ksana Health Inc. received a Phase 1 Small Business Innovation Research (SBIR) Project Grant of $812,902 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded on July 15, 2025, with a completion date of April 30, 2026. The award funds technical development and user-centered research to extend the VIRA mobile application platform—a digitally enhanced behavior change platform previously used...
- Federal Project Grant Award Summary Boston University Medical Campus received a $193,752 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective February 15, 2026 through January 31, 2031. The award supports research on adolescent exposure to nicotine and tobacco product (NTP) content on social media platforms by incorporating youth experiences and social media analytics to improve exposure assessment...
- Federal Grant Award Summary Clemson University received a $353,508 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective June 15, 2025, with a completion date of May 31, 2030. This K01 Career Development Award supports the principal investigator's professional development as an independent clinical research scientist focused on implementing electronic cigarette (EC) protocols to reduce combustible...
- Federal Grant Award Summary Award Details: Funding Agency: National Institute on Drug Abuse (NIDA) Federal Grant Program: Drug Use and Addiction Research Programs (CFDA 93.279) Award Amount: $357,806 Award Date: August 1, 2025 Project Period: August 1, 2025 – July 31, 2030 Recipient: Indiana University Indianapolis Research and Services Delivered: This K23 mentored researcher development award funds a five-year neuroimaging research project investigating the neurobiological predictors of...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of California, Berkeley a $1.596M Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025, and concluding May 31, 2030. This award funds research to develop and test the efficacy of web-based Regulation of Craving Training (ROC-T), a brief digital behavioral intervention designed to enhance smokers' ability to regulate tobacco cravings. The intervention...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Project Grant Award Summary Dartmouth College received a $450,313 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 1, 2025, through May 31, 2027. The award funds research investigating the impact of psychotherapeutic advertising claims (PAC) and mental health warning labels on cannabis purchasing behaviors among light-to-moderate cannabis users experiencing depression and/or anxiety symptoms....
- Federal Grant Award Summary George Washington University received a $159,139 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective August 15, 2025, with a completion date of July 31, 2030. The award supports research investigating the impact of derived psychoactive cannabis product (DPCP) marketing on perceptions and use patterns among young adults. This research addresses a significant public health...
- Federal Grant Award Summary The University of California, San Diego received a $187,777 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal research examining the interactive effects of caffeine and cannabis use on neurocognitive outcomes in adolescents and young adults. The five-year project, awarded September 1, 2025, and extending through August 31, 2030, addresses a significant gap in the...
Kaiser Foundation Research Institute received a $681,667 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective April 1, 2026, through March 31, 2029. The award supports a phased research initiative examining e-cigarette and cannabis co-use among young adults in Hawaii. During the R61 phase, the awardee will conduct epidemiological analysis utilizing data from the Behavioral Risk Factor Surveillance System (BRFSS) and the Young Adult Health Behavior Survey (YAHB) to identify psychosocial determinants and risk factors driving co-use patterns, with particular emphasis on social influences, community factors, and marketing impacts on initiation, escalation, and maintenance behaviors across the target population ages 18-30. In the subsequent R33 phase, Kaiser Foundation Research Institute will develop and pilot a Just-In-Time Adaptive Intervention (JITAI) delivered via smartphone application to address identified risk factors and intervention needs. The intervention will be calibrated based on epidemiological findings, with particular attention to susceptible populations such as low-income young adults. The research is intended to produce a scalable, evidence-based intervention addressing a significant public health gap, as co-use of e-cigarettes and cannabis among young adults, particularly in geographically distinct regions, remains understudied despite demonstrated associations with substance dependence and adverse health outcomes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $681.7k | 2/19/26 |